What is the recommended treatment for group B strep (Streptococcus agalactiae) in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus (GBS) in Pregnancy

Intravenous penicillin G (5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery) is the first-line treatment for intrapartum prophylaxis of Group B Streptococcus in pregnancy, with ampicillin as an acceptable alternative. 1

Screening and Indications for Treatment

Universal Screening

  • All pregnant women should undergo screening for GBS colonization between 36 0/7 and 37 6/7 weeks' gestation (updated from previous recommendation of 35-37 weeks) 1, 2
  • Screening involves collecting both vaginal and rectal specimens 3

Indications for Intrapartum Antibiotic Prophylaxis (IAP)

IAP is indicated in the following situations:

  • Positive GBS vaginal-rectal screening culture in current pregnancy
  • GBS bacteriuria during any trimester of current pregnancy
  • Previous infant with invasive GBS disease
  • Unknown GBS status at labor onset with any of the following risk factors:
    • Delivery at <37 weeks' gestation
    • Amniotic membrane rupture ≥18 hours
    • Intrapartum temperature ≥100.4°F (≥38.0°C) 3, 1

When IAP is NOT Indicated

  • Colonization with GBS during a previous pregnancy (unless another indication exists in current pregnancy)
  • Negative vaginal and rectal GBS screening culture in current pregnancy, regardless of intrapartum risk factors
  • Cesarean delivery performed before labor onset with intact amniotic membranes, regardless of GBS status or gestational age 3

Antibiotic Regimens

First-Line Treatment

  • Penicillin G: 5 million units IV initial dose, then 2.5-3.0 million units IV every 4 hours until delivery
  • Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours until delivery 1

For Penicillin-Allergic Women

For women with non-anaphylactic penicillin allergy:

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours until delivery

For women with history of anaphylaxis to penicillin:

  • Clindamycin: 900 mg IV every 8 hours until delivery (if isolate is susceptible)
  • Vancomycin: 1 g IV every 12 hours until delivery (if isolate is resistant to clindamycin or susceptibility unknown) 1

Important Clinical Considerations

Timing of Antibiotics

  • Optimal effectiveness requires administration of antibiotics at least 4 hours before delivery 4
  • Even if 4 hours cannot be achieved before delivery, IAP should still be initiated as soon as possible 5

Treatment of GBS UTI During Pregnancy

  • GBS bacteriuria at any colony count indicates heavy genital tract colonization
  • Treat with appropriate antibiotics for UTI (oral amoxicillin is appropriate for outpatient treatment)
  • Treatment should continue for 5-7 days for uncomplicated UTIs and 10-14 days for complicated UTIs 1
  • Even after treatment, intrapartum antibiotic prophylaxis is still required during labor 1

Common Pitfalls to Avoid

  1. Do not treat GBS colonization with oral antibiotics before labor: This is ineffective at eliminating carriage or preventing neonatal disease, as 30-70% of treated women remain colonized at delivery 1

  2. Do not use erythromycin for GBS prophylaxis: It is no longer recommended due to increasing resistance and poor placental transfer 1

  3. Perform susceptibility testing for penicillin-allergic patients: This is essential due to increasing resistance to alternative antibiotics 1

  4. Do not miss opportunities for prophylaxis in preterm labor: Women with threatened preterm delivery should be screened and managed according to specific algorithms 3, 2

  5. Do not assume cesarean delivery eliminates need for prophylaxis: IAP is still indicated if labor begins or membranes rupture before cesarean delivery in GBS-positive women 3

The implementation of universal screening and IAP has reduced early-onset GBS disease incidence by more than 80% in the United States, preventing an estimated 70,000 cases between 1994 and 2010 5. However, IAP does not prevent late-onset GBS disease, which typically occurs after the first week of life 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.